Condition
IBI363 + Chemotherapy clinical trials and research
As of November 12, 2026, Find a Trial lists 2 IBI363 + Chemotherapy clinical trials that are recruiting, in China. By phase: Phase 1 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Perioperative IBI363 plus chemotherapy for MHC-II–negative locally advanced gastric and gastroesophageal junction adenocarcinoma
Tests whether adding the experimental drug IBI363 to standard perioperative chemotherapy helps adults (18–75) with MHC‑II–negative locally advanced gastric or gastroesophageal junction adenocarcinoma.
-
Evaluating IBI363 with chemotherapy for advanced gastric cancer
This study is testing a new treatment combining IBI363 with chemotherapy for people with advanced stomach cancer to see if it helps them better than current options.
Quick answers
How many IBI363 + Chemotherapy clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.